Skip to main content

Table 1 Characteristics of eligible population receiving colonoscopy/FOBT, mammography or PSA testing in 2018

From: Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study

 

Colonoscopy/FOBTa

No Colonoscopy/FOBTa

Mammo-graphy

No Mammography

PSA testingb

No PSA testingb

N (%)

22′453 (9.2)

221′875 (90.8)

33′747 (20.4)

131′581 (79.6)

49′521 (31.8)

106′423 (68.2)

Male sex (%)

10′876 (48.4)

107′027 (48.2)

0 (0)

0 (0)

49′521 (100)

106′423 (100)

Age in years (mean, sd)

59.8 (5.94)

59.0 (5.90)

61.1 (7.17)

61.9 (7.43)

64.0 (7.36)

60.5 (7.48)

High deductible (%)

4′869 (21.7)

67′033 (30.2)

5′990 (17.7)

30′831 (23.4)

10′204 (20.6)

38′822 (36.5)

Managed care (%)

13′708 (61.1)

134′626 (60.7)

20′684 (61.3)

78′601 (59.7)

29′346 (59.3)

63′850 (60.0)

Suppl. hospital insurance (%)

5′620 (25.0)

48′174 (21.7)

9′795 (29.0)

33′285 (25.3)

12′909 (26.1)

20′838 (19.6)

Language region

 German (%)

16′659 (74.2)

172′012 (77.5)

19′994 (59.2)

106′389 (80.9)

35′531 (71.7)

85′961 (80.8)

 French (%)

3′629 (16.2)

34′750 (15.7)

9′297 (27.5)

17′196 (13.1)

8′724 (17.6)

14′485 (13.6)

 Italian (%)

2′165 (9.6)

15′113 (6.8)

4′456 (13.2)

7′996 (6.1)

5′266 (10.6)

5′977 (5.6)

 Urban region (%)

17′527 (78.1)

169′001 (76.2)

26′611 (78.9)

101′054 (76.8)

38′503 (77.8)

79′373 (74.6)

 Major related surgery/ disease (%)

269 (1.2)

696 (0.3)

2′022 (6.0)

1′164 (0.9)

2′398 (4.8)

1′011 (0.9)

 Chronic conditions (mean, sd)

1.8 (1.87)

1.4 (1.70)

1.8 (1.87)

1.6 (1.85)

2.0 (1.79)

1.3 (1.66)

 Cantonal program (%)

1′359 (6.1)

12′526 (5.6)

21′654 (64.2)

61′795 (47.0)

0 (0)

0 (0)

  1. a FOBT Fecal occult blood testing
  2. b PSA Prostate-specific antigen